Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibodies for molecular imaging in the cardiovascular system.

Literature DB >> 16171720

Antibodies for molecular imaging in the cardiovascular system.

Ban-An Khaw¹.

Abstract

Mesh：

Substances：

Year: 2005 PMID： 16171720 DOI： 10.1016/j.nuclcard.2005.07.001

Source DB: PubMed Journal: J Nucl Cardiol ISSN： 1071-3581 Impact factor: 5.952

× No keyword cloud information.

64 in total

1. [Scintigraphy using 111In-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement].

Authors: T Krause; C Schümichen; A Beck; B Lang; S Hohnloser; E Moser
Journal: Nuklearmedizin Date: 1990-08 Impact factor: 1.379

2. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer.

Authors: M Estorch; I Carrió; L Berná; C Martínez-Duncker; C Alonso; J R Germá; B Ojeda
Journal: J Nucl Med Date: 1990-12 Impact factor: 10.057

3. The zone of activity of antibodies as determined by the use of radioactive tracers; the zone of activity of nephritoxic antikidney serum.

Authors: D PRESSMAN; G KEIGHLEY
Journal: J Immunol Date: 1948-06 Impact factor: 5.422

4. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.

Authors: I Carrió; L Berná; M Ballester; M Estorch; D Obrador; M Cladellas; L Abadal; M Ginjaume
Journal: J Nucl Med Date: 1988-12 Impact factor: 10.057

5. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy.

Authors: T S Hall; W A Baumgartner; A M Borkon; N D LaFrance; T A Traill; S Norris; G M Hutchins; J Brawn; B A Reitz
Journal: J Heart Transplant Date: 1986 Nov-Dec

6. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy.

Authors: J W Mason; M E Billingham; D R Ricci
Journal: Am J Cardiol Date: 1980-05 Impact factor: 2.778

7. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.

Authors: W Frist; T Yasuda; G Segall; B A Khaw; H W Strauss; H Gold; E Stinson; P Oyer; J Baldwin; M Billingham
Journal: Circulation Date: 1987-11 Impact factor: 29.690

8. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

Authors: Christian M Matter; Pia K Schuler; Patrizia Alessi; Patricia Meier; Romeo Ricci; Dongming Zhang; Cornelia Halin; Patrizia Castellani; Luciano Zardi; Christoph K Hofer; Matteo Montani; Dario Neri; Thomas F Lüscher
Journal: Circ Res Date: 2004-11-11 Impact factor: 17.367

Antibodies for molecular imaging in the cardiovascular system.

1. [Scintigraphy using 111In-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement].

2. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer.

3. The zone of activity of antibodies as determined by the use of radioactive tracers; the zone of activity of nephritoxic antikidney serum.

4. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.

5. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy.

6. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy.

7. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.

8. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

9. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy.

10. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis.

Review 1. Molecular imaging will replace perfusion imaging: The impossible dream.

Review 2. Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.